Precision Medicine Is Critical for the Future of Oncology: Johannes Czernin and Ken Herrmann Talk with Chris Behrenbruch on Theranostics, Imaging, and the Urgency to Innovate

By afschroeder • August 15, 2025

Behrenbruch C, Herrmann K, Czernin J. Precision Medicine Is Critical for the Future of Oncology: Johannes Czernin and Ken Herrmann Talk with Chris Behrenbruch on Theranostics, Imaging, and the Urgency to Innovate. J Nucl Med. 2025 Aug 14:jnumed.125.270966. doi: 10.2967/jnumed.125.270966. Epub ahead of print. PMID: 40813237.

Tags: Cardiology/Epi, Publications

Public Reporting of Quality and Clinical Outcomes in the Get With The Guidelines-Stroke Registry

Mullen MT, Zhao J, Jiang T, Gao Z, Buechner J, Wahab F, Seo MH, Harder B, Schwamm LH, Fonarow GC, Smith EE, Xian Y, Messé[...]

Myeloid Fmr1 deficiency in mice results in reduced serum cholesterol and altered bile pathway gene expression

Zhao X, Zhou J, Chyu KY, Erbay E, Cercek B, Shah PK, Dimayuga PC. Myeloid Fmr1 deficiency in mice results in reduced serum cholesterol and[...]

When Less Is More: Is It Time for a New Gold Standard?

Tan W, Aboulhosn J. When Less Is More: Is It Time for a New Gold Standard? Circulation. 2026 Jan 13;153(2):82-85. doi: 10.1161/CIRCULATIONAHA.125.077517. Epub 2026 Jan[...]